EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Utilizing the Gut Microbiome as a Therapeutic Target for Liver Disease – Narrative Review

Dharma Ayer, Alexa Trovato, Micheal Tadros

Journal of Translational Gastroenterology · 2023

DOI: 10.14218/jtg.2023.00027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Translational Gastroenterology, 2023. Verfasst von Dharma Ayer und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiome has been well-established in its role of regulating the onset of many gastrointestinal disorders. Recent evidence has shown a bidirectional relationship between the intestinal microbiota and the liver. The gut microbiome may affect liver disease progression through its bacterial composition, the metabolism of bile acids, and the translocation of bacterial products. Modulation of dysbiosis may be considered as a potential therapeutic target for liver disease regardless of the underlying cause. Continuing to identify parts of the gut-liver axis that are disordered in different etiologies of liver disease may offer insight into potential interventions to restore homeostasis. Thus, this review will focus on exploring some of the major gut microbiome targeted therapies for liver disease, including probiotics, prebiotics, and fecal microbiota transplantation.

Zitieren

APA

Ayer, D., Trovato, A., & Tadros, M. (2023). Utilizing the Gut Microbiome as a Therapeutic Target for Liver Disease – Narrative Review. Journal of Translational Gastroenterology. https://doi.org/10.14218/jtg.2023.00027

Vancouver

Ayer D, Trovato A, Tadros M. Utilizing the Gut Microbiome as a Therapeutic Target for Liver Disease – Narrative Review. Journal of Translational Gastroenterology. 2023. doi:10.14218/jtg.2023.00027

BibTeX
@article{Ayer2023,
  author = {Ayer, Dharma and Trovato, Alexa and Tadros, Micheal},
  title = {Utilizing the Gut Microbiome as a Therapeutic Target for Liver Disease – Narrative Review},
  journal = {Journal of Translational Gastroenterology},
  year = {2023},
  doi = {10.14218/jtg.2023.00027}
}
Kostenlos starten →